Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

被引:4
|
作者
Chen, Xi [1 ]
Guo, Jishu [2 ]
Zhou, Fan [3 ]
Ren, Wenjun [4 ]
Huang, Xiaobin [1 ]
Pu, Jun [1 ]
Niu, Xiaoqun [5 ]
Jiang, Xiulin [6 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 2, Dept Neurosurg, Kunming, Peoples R China
[2] Yunnan Univ, Inst forEcol Res & Pollut Control Plateau Lakes, Sch Ecol & Environm Sci, Kunming, Peoples R China
[3] Puer Peoples Hosp, Hematol & Rheumatol Dept, Puer, Peoples R China
[4] First Peoples Hosp Yunnan Prov, Dept Cardiovasc Surg, Kunming, Peoples R China
[5] Kunming Med Univ, Second Hosp, Dept Resp Med, Kunming, Peoples R China
[6] Univ Chinese Acad Sci, Kunming Coll Life Sci, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
AL139385; 1; lung adenocarcinoma; prognosis biomarker; DNA methylation; ceRNA; cell proliferation; cell migration; CELL-PROLIFERATION; CANCER; RETRACTION; EXPRESSION;
D O I
10.3389/fonc.2022.905871
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung adenocarcinoma (LUAD) is the most common histological lung cancer, and it is the leading cause of cancer-related deaths worldwide. LncRNA-AL139385.1 (ENSG00000275880) is a novel lncRNA that is abnormally expressed in various cancer types including LUAD. However, the underlying biological function and potential mechanisms of AL139385.1 driving the progression of LUAD remain unclear. In this study, we investigated the role of AL139385.1 in LUAD and found that DNA hypomethylation was positively correlated with AL139385.1 expression in LUAD. Moreover, we uncover that the expression of AL139385.1 in LUAD tissues was significantly higher than that of AL139385.1 expression in adjacent normal tissues. Kaplan-Meier survival analysis showed that patients with higher AL139385.1 expression correlated with adverse overall survival and progression-free survival. Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) value of AL139385.1 was 0.808. Correlation analysis showed that AL139385.1 expression was associated with immune infiltration in LUAD. We also found that AL139385.1 was upregulated in LUAD cancer tissues and cell lines. Knockdown of AL139385.1 significantly inhibited cell proliferation and migration abilities of LUAD. Finally, we constructed a ceRNA network that includes hsa-miR-532-5p and four mRNAs (GALNT3, CYCS, EIF5A, and ITGB4) specific to AL139385.1 in LUAD. Subsequent Kaplan-Meier survival analysis suggested that polypeptide N-acetylgalactosaminyltransferase 3 (GALNT3), cytochrome c, somatic (CYCS), eukaryotic translation initiation factor 5A (EIF5A), and integrin subunit beta 4 (ITGB4), were potential prognostic biomarkers for patients with LUAD. In conclusion, this finding provides possible mechanisms underlying the abnormal upregulation of AL139385.1 as well as a comprehensive view of the AL139385.1-mediated competing endogenous RNAs (ceRNA) network in LUAD, thereby highlighting its potential role in diagnosis and therapy.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Novel long non-coding RNA as a potential biomarker of liver cancer
    Burenina, O.
    Lazarevich, N.
    Zatsepin, T.
    Rubtsova, M.
    Dontsova, O.
    FEBS OPEN BIO, 2019, 9 : 40 - 40
  • [22] Clinical significance of long non-coding RNA EWSAT1 as a novel prognostic biomarker in osteosarcoma
    Zhang, G. -Y.
    Zhang, J. -F.
    Hu, X. -M.
    Luo, Z. -P.
    Ma, Y. -Z.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (23) : 5337 - 5341
  • [23] Identification of potential prognostic long non-coding RNA signatures based on a competing endogenous RNA network in lung adenocarcinoma
    Wang, Xiaojuan
    Ding, Yawen
    Da, Bangming
    Fei, Yan
    Feng, Gang
    ONCOLOGY REPORTS, 2018, 40 (06) : 3199 - 3212
  • [24] Revealing potential long non-coding RNA biomarkers in lung adenocarcinoma using long non-coding RNA-mediated competitive endogenous RNA network
    Zhu, T-G.
    Xiao, X.
    Wei, Q.
    Yue, M.
    Zhang, L-X.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2017, 50 (09)
  • [25] Long non-coding RNA in lung cancer
    Chen, Zhenyao
    Lei, Tianyao
    Chen, Xin
    Gu, Jingyao
    Huang, Jiali
    Lu, Binbin
    Wang, Zhaoxia
    CLINICA CHIMICA ACTA, 2020, 504 : 190 - 200
  • [26] Construction of a Ferroptosis-Related Long Non-coding RNA Prognostic Signature and Competing Endogenous RNA Network in Lung Adenocarcinoma
    Fei, Xiang
    Hu, Congli
    Wang, Xinyu
    Lu, Chaojing
    Chen, Hezhong
    Sun, Bin
    Li, Chunguang
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [27] Long non-coding RNA Linc00261 as a novel potential diagnostic and prognostic biomarker for gallbladder cancer
    Niu, Jia-Zeng
    Liang, Xian-Chun
    Xu, Zhou-Wei
    Li, Zhen-Huan
    Li, Ji
    Meng, Yong
    Sun, Zhi-Wei
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6078 - 6085
  • [28] Discovery and characterization of a novel long non-coding RNA in lung cancer
    Ri, Sho
    Zhang, Xuhong
    Hamada, Akira
    Tachibana, Hirohiko
    Konta, Tsuneo
    CANCER SCIENCE, 2018, 109 : 1422 - 1422
  • [29] Long non-coding RNA SAMMSON as a novel potential diagnostic and prognostic biomarker for oral squamous cell carcinoma
    Zheng, Xijiao
    Tian, Xia
    Zhang, Qiao
    Shi, Ping
    Li, Shu
    JOURNAL OF DENTAL SCIENCES, 2020, 15 (03) : 329 - 335
  • [30] A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
    Zhou, Chenhao
    Wang, Shun
    Zhou, Qiang
    Zhao, Jin
    Xia, Xianghou
    Chen, Wanyong
    Zheng, Yan
    Xue, Min
    Yang, Feng
    Fu, Deliang
    Yin, Yirui
    Atyah, Manar
    Qin, Lunxiu
    Zhao, Yue
    Bruns, Christiane
    Jia, Huliang
    Ren, Ning
    Dong, Qiongzhu
    FRONTIERS IN ONCOLOGY, 2019, 9